Melissa Baxter Marina Morgan
10.3201/eid2301.161009
Emerg Infect Dis
2017 Jan;23(1):127-129.
ivig stss bacteria bacterial infections group g streptococcus intravenous immunoglobulin streptococcal toxic shock syndrome streptococci streptococcus
CC BY
https://pubmed.ncbi.nlm.nih.gov/27983491/
Anti-Bacterial Agents / therapeutic use Immunoglobulins, Intravenous / therapeutic use Shock, Septic / drug therapy Streptococcal Infections / drug therapy Streptococcus / classification
Anti-Bacterial Agents / therapeutic use Immunoglobulins, Intravenous / therapeutic use Shock, Septic / drug therapy Streptococcal Infections / drug therapy Streptococcus / classification Case Reports Aged Female Humans Male Middle Aged Serotyping Shock, Septic / microbiology Shock, Septic / pathology Shock, Septic / surgery Streptococcal Infections / microbiology Streptococcal Infections / pathology Streptococcal Infections / surgery Streptococcus / drug effects Streptococcus / genetics Streptococcus / pathogenicity Treatment Outcome United Kingdom Anti-Bacterial Agents Immunoglobulins, Intravenous
PMC5176243
27983491
Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom
2017